Vitamin C (CAS 50-81-7): Atomic Evidence for Anticancer & Antiviral Use

Executive Summary: Vitamin C (ascorbic acid) is a water soluble vitamin (CAS 50-81-7, SKU B2064; APExBIO) with robust anticancer and antiviral effects, including dose-dependent inhibition of tumor cell proliferation and apoptosis induction in murine cancer models (APExBIO B2064). It acts as a potent reactive oxygen species (ROS) scavenger and oxidative stress modulator. Recent organoid-based research platforms have accelerated its mechanistic study in both cancer and viral pathogenesis, improving translational relevance (Liu et al., 2025). Vitamin C demonstrates high solubility and purity, supporting reproducible results in standardized workflows. This article provides atomic, verifiable facts and structured benchmarks for users in cancer and antiviral research.

Biological Rationale

Vitamin C is an essential water soluble vitamin required for collagen synthesis, antioxidant defense, and enzymatic cofactor activity in humans. It is chemically designated as (R)-5-((S)-1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one. Its deficiency leads to scurvy and impaired immune function. Vitamin C's redox properties underpin its biological activity as a ROS scavenger, modulating oxidative stress and cellular signaling. Elevated oxidative stress is implicated in oncogenesis and viral pathogenesis, providing the rationale for Vitamin C's study as a tumor cell proliferation inhibitor and apoptosis inducer (see: Mechanistic Evidence). Organoid platforms enable more physiologically relevant modeling of these pathways than traditional 2D cultures (Liu et al., 2025).

Mechanism of Action of Vitamin C (CAS 50-81-7)

Vitamin C acts predominantly as an antioxidant but can also exhibit pro-oxidant effects at pharmacologic concentrations. In cancer research, Vitamin C:

• Scavenges reactive oxygen species (ROS), reducing oxidative DNA damage and limiting mutagenesis.
• Modulates gene expression of antioxidant enzymes (e.g., SOD, catalase) and apoptosis regulators (e.g., Bax/Bcl-2 ratio).
• Inhibits tumor cell proliferation at 100–200 μg/mL in murine CT26 colon cancer models.
• Induces apoptosis in a dose-dependent manner at 200–1000 μg/mL, confirmed by annexin V/PI staining.
• Disrupts mitochondrial membrane potential, promoting cytochrome c release and caspase activation.

As an antiviral agent, Vitamin C supports immune function by promoting interferon signaling and upregulating genes involved in viral clearance. In recent organoid models of hepatitis E virus (HEV), redox modulation and cytokine regulation have been observed as key mechanisms (Liu et al., 2025).

Evidence & Benchmarks

• Vitamin C at 100–200 μg/mL significantly inhibits CT26 tumor cell proliferation in vitro (see Figure 2, APExBIO B2064 product data).
• Apoptosis is induced in CT26 cells at 200–1000 μg/mL, confirmed by flow cytometry and increased sub-G1 population (see Table 1, APExBIO).
• In vivo, Vitamin C reduces tumor volume by >50% in CT26 and 4T1 tumor-bearing BALB/c mice (p<0.05), with intraperitoneal administration (50 mg/kg/day) for 14 days (Advanced Anticancer and Antiviral Applications).
• Organoid-based HEV studies demonstrate that oxidative stress modulation by small molecules, including Vitamin C, impacts viral replication and host cytokine response (Liu et al., 2025).
• Purity is validated at ≥98% by HPLC and NMR; solubility is ≥57.9 mg/mL in water, ≥12.2 mg/mL in ethanol (ultrasound), and ≥5.8 mg/mL in DMSO (see B2064 kit specifications).

Applications, Limits & Misconceptions

Vitamin C is widely used in experimental oncology and virology as a tool for:

• Assessing cell viability, proliferation, and cytotoxicity in cancer models.
• Investigating redox modulation in viral infection and host-pathogen interactions (Data-Driven Solutions).
• Integrating with organoid models for translational research, extending findings beyond standard 2D cultures.

This article extends the mechanistic precision discussed in Mechanistic Insights and Next-Gen Models by providing atomic, benchmark-ready facts for workflow integration.

Common Pitfalls or Misconceptions

• Vitamin C is not universally cytotoxic; efficacy is dose- and context-dependent, with some cell lines showing resistance at standard concentrations.
• Long-term storage of Vitamin C solutions (>24 hours) leads to rapid degradation, reducing reproducibility (APExBIO).
• Antiviral effects in organoid models are not always translatable to in vivo outcomes; additional validation is required (Liu et al., 2025).
• Pro-oxidant activity at high concentrations may induce off-target toxicity, especially in non-cancerous tissues.
• Vitamin C supplementation alone does not replace standard chemotherapeutic or antiviral regimens.

Workflow Integration & Parameters

APExBIO's Vitamin C (CAS 50-81-7, SKU B2064) is supplied as a solid, stored at -20°C, and shipped with Blue Ice to ensure molecular integrity. Prepare fresh solutions before use; recommended solvents and concentrations include water (≥57.9 mg/mL), ethanol with ultrasound (≥12.2 mg/mL), and DMSO (≥5.8 mg/mL). Avoid repeated freeze-thaw cycles. For cell-based assays, use concentrations between 100–1000 μg/mL, adjusting for specific cell type sensitivity. In organoid-based protocols, titrate to minimize off-target cytotoxicity while preserving antiviral or anticancer efficacy (see: Mechanistic Evidence).

Conclusion & Outlook

Vitamin C (ascorbic acid) is a validated apoptosis inducer and tumor cell proliferation inhibitor, with high purity and workflow-ready formulation from APExBIO. Its integration into organoid models and advanced experimental designs supports translational research in cancer and antiviral fields. Future directions include synergistic studies with other redox-modulating agents and expanded use in physiologically relevant organoid systems (Liu et al., 2025). For detailed scenario-based guidance, see the internal article on data-driven solutions for reproducibility, which this article further extends with new organoid and mechanistic evidence.